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GNE myopathy is a distal dominant myopathy with characteristic sparing of quadriceps, which is known 
to be caused by mutation of the GNE gene. Recently, there were some reports of thrombocytopenia 
that concurred with GNE myopathy. We also present a case of GNE myopathy with thrombocytopenia, 
having c.1664C>T (p.A555V) and c.1807G>C(p.V603L) mutations. These two are already well-known 
mutations, found commonly in multiple reports. We reviewed other cases of thrombocytopenia in GNE 
myopathy and concluded that thrombocytopenia may not be restricted to any specific mutation in the 
GNE gene or any one of two enzymes. Even so, a GNE gene defect can be the causative mutation 
for these cases of congenital thrombocytopenia, considering that hyposialylation of platelets may 
cause shortening of its lifespan, and the incidence of thrombocytopenia in GNE myopathy is much 
higher than in the normal population.
Mutations in the GNE gene are known to cause myo-
pathy with characteristic clinical features.1 Symptoms typi-
cally begin in the 2nd to 3rd decade of life and include 
weakness progressing slowly from the distal leg to proximal 
parts, including the arms, with sparing of the quadriceps.
A few reports of congenital thrombocytopenia in con-
currence with GNE myopathy have recently been pub-
lished,2-4 and mutations in the GNE gene are considered as 
the underlying genetic etiology of thrombocytopenia in 
these cases. Here, we report a case of GNE myopathy with 
congenital thrombocytopenia, and explore the possibility of 
thrombocytopenia as a clinical manifestation of mutations 
in the GNE gene. 
대한 신 경근 육 질환 학 회지  20 186
Korean Journal of Neuromuscular Disorders Vol. 10 No. 1, 2018
A  B
Figure 1. (A) Pedigree showing the two affected siblings without any involvement in their parents. (B) Sequence chromatograms 
containing pathogenic variant of p.A555V and p.V603L.
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Genomic variants p.Y217H
D515Qfs*2
p.V603L
p.R39X
p.V603L
p.414insT
p.V603L
p.R451X
p.V603L
p.G739S
p.V603L
p.A555V
Age of onset 25 N/A N/A N/A 14-16 (middle adolescence) 17
Age at diagnosis 29 N/A N/A N/A 20 19
Clinical presentation Distal dominant weakness N/A N/A N/A
Proximal lower limb 
dominant
Distal dominant 
weakness
Serum creatine kinase 
  (IU/L) 330 N/A N/A N/A 300-600 401
Platelet count (k/µL) 36 N/A N/A N/A 1.7-16.2 100
Pathologic finding Myopathic changes with rimmed vacuoles N/A N/A N/A
Myopathic changes 
with rimmed vacuoles
Nonspecific 
myopathic changes
Reference Zhen et al.4 (2014) Mori-Yoshimura et al.3 (2014) Izumi et al.2 (2014) Current case
N/A, not applicable.
Table 1. The review of previously reported and current cases of GNE myopathy with thrombocytopenia
Case
A 19-year-old male was referred to our hospital due to 
bilateral leg weakness from the age of 17. He was pre-
viously a soccer player, indicating that he had normal func-
tionality before symptom onset. At the age of 17, his toe 
gait first became impaired, followed by impairments in 
running. Upper extremity involvement was minimal, but 
sit-ups and pushups became more difficult a year after 
onset. At the age of 19, the patient’s proximal leg weakness 
progressed so that he needed to use his arms to stand up 
from sitting on the floor, and he could no longer run.
In terms of family history, the patient’s younger brother 
had been diagnosed with thrombocytopenia of uncertain eti-
ology (Fig. 1A). He was 3 years younger than the patient, 
and had complained of running difficulty for a year. 
However, he refused further evaluation, including genetic 
testing for a GNE mutation. 
Neurologic examination showed distal dominant lower 
extremity weakness with sparing of the quadriceps. Sensory 
examinations were normal and deep tendon reflexes were 
hyporeflexive.
Lab tests showed elevation of creatine kinase (CK, 401 
units/L), aldolase (13.4 units/L), and lactate dehydrogenase 
(522 IU/L). Complete blood count revealed thrombocytope-
nia (100 k/µL) without clumping on a peripheral blood 
smear. Hematology was consulted for evaluation of throm-
bocytopenia, and abdominal sonography showed splenome-
galy (13.8 cm) without any remarkable findings in other 
organs. However, a definite etiology for thrombocytopenia 
could not be found. 
An electrophysiological study revealed active myopathy 
without any evidence of neuropathy. Myopathic changes 
were found on a muscle biopsy, but there was no evidence 
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of myositis or rimmed vacuoles in muscle staining.
Clinical features of distal myopathy with sparing of the 
quadriceps, and relatively late onset with slow progression 
to proximal muscles raised suspicion for GNE myopathy. 
Direct sequencing of the GNE gene was performed with 
NM_001128227.2 as a reference sequence. Two missense 
mutations of c.1664C>T (p.A555V) and c.1807G>C 
(p.V603L) were found, confirming the diagnosis of GNE 
myopathy (Fig. 1B).
Conclusion
Defects in the GNE gene are known to cause hypo-
sialylation of muscles, which is thought to be the etiology 
for the resulting myopathy. Sialic acid is also present in the 
membrane of platelets, and forms during the process of 
glycosylation. Sialic acid deficiencies in the platelet mem-
brane can shorten the lifespan of a platelet, causing 
thrombocytopenia.5 In this context, the incidence of throm-
bocytopenia in a patient registry from Japan was found to be 
158 times higher than the general population.3 Considering 
the aforementioned role of sialic acid in platelet lifespan 
and the familial occurrence of both myopathy and thrombo-
cytopenia in both siblings, a GNE gene mutation may be the 
causative etiology for thrombocytopenia in these patients.
The two mutations found in our patients were already 
well-known mutations in the GNE gene. The p.V603L mu-
tation is the most common type found in Korea and 
Japan,6,7 while the p.A555V mutation was designated as the 
second most common in a patient series in China.8 However, 
thrombocytopenia was not a typical feature in patients with 
these same mutations.
In 6 cases from 4 reports of thrombocytopenia,2-4 includ-
ing ours, five cases (83%) had the p.V603L mutation 
(Table 1). However, considering all five cases with the 
p.V603L mutation were from Korea and Japan, and this 
mutation is the most common in these areas, its sig-
nificance is questionable. Also, 3 of the 6 cases (50%) had 
mutations in both the epimerase and kinase domain, while 
the other half only had mutations in the kinase domain. 
Considering the above results, thrombocytopenia may not 
be restricted to any specific mutation in the GNE gene or 
in any one of the two enzymes. No assumption could be 
made for any association between other clinical features 
and thrombocytopenia. Case 5 showed proximal lower limb 
weakness as the dominant clinical feature, and no clinical 
features were described for 3 of 6 cases (Table 1). 
We present a case of GNE myopathy with thrombocytopenia. 
The mutations identified in this case were commonly found 
in other GNE myopathy cases, and no specific geno-
type-phenotype correlation could be determined for the 
thrombocytopenia. However, considering that hypo-
sialylation in platelets can cause shortening of their lifespan 
and the prevalence of thrombocytopenia in GNE myopathy 
is higher than in the general population, congenital throm-
bocytopenia may be a feature of mutations in the GNE 
gene.
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